Skip to main content

Advertisement

Table 3 Sensitivity analysis – using opportunity cost value of household production, instead of replacement cost

From: Projecting productivity losses for cancer-related mortality 2011 – 2030

Cancer Total lost household productivity (base case) Total lost household productivity (opportunity cost) % of base case
  (Million €) (Million €) %
C01-C14: mouth & pharynx €954 €975 102
C15: oesophagus €2322 €2067 89
C16: stomach €2265 €1824 81
C18-C21: colorectal €6567 €4571 70
C22: liver €1682 €1330 79
C25: pancreas €3355 €2392 71
C34: lung €12,493 €8730 70
C43: melanoma skin €1109 €1096 99
C44: non-melanoma skin €492 €374 76
C50: breast €7194 €3444 48
C53: cervix €1218 €763 63
C54: corpus uteri €706 €239 34
C56: ovary €2626 €987 38
C61: prostate €2794 €1911 68
C62: testis €81 €175 217
C64: kidney €1374 €1228 89
C67: bladder €1240 €830 67
C70-C72: brain and CNS €2164 €2129 98
C81-C85: lymphoma (total) €1989 €1483 75
C90: multiple myeloma €1032 €670 65
C91-C95: leukaemia (total) €1691 €1267 75
Other invasive cancers bar specified €6282 €4286 68
C00-C96: all invasive cancer deaths €60,427 €41,286 68